NEW YORK (GenomeWeb) – The New York Genome Center has won $13.5 million under the National Heart, Lung and Blood Institute's Trans-Omics for Precision Medicine (TOPMed) program, the center said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.
In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.